System uses ultraviolet light system to kills advanced viruses and bacteria in minutes.
In an effort to address the ever-present decontamination concerns and priorities surrounding CT scanners used to image patients who are suspected of or have tested positive for COVID-19, Canon Medical System revealed, this week, a mobile CT unit that offers a rapid cleaning system.
In most cases, based on industry guidance, a CT scanner has been decommissioned for roughly an hour between scanning patients to minimize the likelihood of viral transmission. According to a company statement, the Aquilion™ Prime SP CT system can cut the cleaning time down to minutes by using an automated ultraviolet light system.
“Imaging infectious disease patients is not a new phenomenon for medical providers. But, our customers are facing an unprecedented number of potentially contagious patients,” said Erin Angel, managing director of Canon Medical System’s CT Business Unit, in a statement. “Our deployable CT offerings with the addition of rapid UV-C decontamination will offer providers a unique solution to help improve their workflow and safety as they image infectious disease patients.”
Available as a modular or mobile footprint, the system can be isolated from other staff and patients, creating a safer environment for imaging patients who are suspected of having COVID-19. The decontamination system reduces bacteria, spores, and viruses and is effective against a myriad of advanced viral infectious diseases, according to the company statement.
The system is available on new deployable CT solutions, as well as existing fixed imaging suites.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.